Skip to main content
Skip to navigation

All Lanfeng Wang articles

News
Protective human monoclonal antibody targets a conserved site of spike glycoprotein of SARS-CoV-2 Omicron variants

2024-03-04T09:13:00Z

Scientists report that mAb-39 greatly improved the neutralizing activity of anti-RBD antibody, the same type of EUA therapeutic monoclonal antibodies, against the highly neutralization-resistant Omicron variants.